Biotech

All Articles

Roivant reveals new 'vant' to accelerate Bayer high blood pressure med

.Matt Gline is back with a brand-new 'vant' provider, after the Roivant Sciences chief executive off...

Viridian eye disease stage 3 smash hits, accelerating push to rival Amgen

.Viridian Therapeutics' period 3 thyroid eye health condition (TED) medical trial has actually reach...

Bain introduces $3B fund forever science firms

.With a sturdy performance history for pinpointing rough diamonds, Bain Capital Everyday Life Scienc...

Genentech's cancer restructure brought in 'for scientific causes'

.The latest selection to merge Genentech's 2 cancer cells divisions was produced "clinical explanati...

Tern oral GLP-1 reveals 5% weight reduction at 1 month at highest possible dosage

.Terns Pharmaceuticals' choice to drop its liver ailment passions may yet pay, after the biotech upl...

Merck, Daiichi replay early effectiveness in tiny cell lung cancer cells along with updated ADC information

.Merck &amp Co.'s long-running initiative to land a hit on little mobile bronchi cancer (SCLC) has s...

Boehringer, Bayer breakthrough bronchi cancer medications towards Astra battle

.Some patients with non-small cell bronchi cancer cells (NSCLC) possess mutations in a genetics call...

MBX pursues $136M IPO to take opponent to Ascendis right into phase 3

.MBX has elaborated plannings to absorb over $136 thousand from its IPO as the biotech aims to bring...

Relay boob cancer cells data tee up clash with AstraZeneca's Truqap

.Relay Therapeutics has actually hammered its own survival target in a first-in-human bust cancer ce...

AZ lays out AI-enabled TROP2 biomarker strategy for Daiichi ADC

.AstraZeneca has made use of artificial intelligence to devise an unique biomarker for its own Daiic...